Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of publishing national dementia outcomes for neighbourhood health services and requiring integrated care boards to demonstrate timely access to specialist, community-based dementia support.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
NHS England already collect and publish data about people with dementia at each general practice in England, to enable National Health Service general practitioners (GPs) and commissioners to make informed choices about how to plan their dementia services around patients’ needs.
The Office for Health Improvement and Disparities Dementia Intelligence Network has also developed a tool for local systems, which includes an assessment of population characteristics such as rurality and socio-economic deprivation. This enables systems to investigate local variation in diagnosis and take informed action to enhance their diagnosis rates. The tool is available via the NHS Futures Collaboration platform.
This Government is empowering local leaders with the autonomy they need to provide the best services to their local community, including those with dementia. That is why we have published the D100: Assessment Tool Pathway programme, which brings together multiple resources into a single, consolidated tool. This will help simplify best practice for system leaders and help create communities and services where the best possible care and support is available to those with dementia. The D100: Pathway Assessment Tool is available at the following link:
We are making progress on building a National Care Service based on higher quality of care, greater choice and control, and joined-up neighbourhood services, with around £4.6 billion of additional funding available for adult social care by 2028/29 compared to 2025/26.
We are strengthening join-up between health and social care services, so that people experience more integrated and person-centred care, by developing neighbourhood health services and reforming the Better Care Fund. This will be fortified by improved national data and digital infrastructure to ensure health and care staff can access real-time information to improve the safety and quality of care.
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of removing the exceptionality requirement for Individual Funding Requires for Chemosaturation therapy and comparable intervention for people whose lives are at risk.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department and the National Health Service in England are committed to ensuring that cancer patients have timely access to treatment and tailored medical support. In 2016, NHS England concluded that there was insufficient evidence to make chemosaturation treatment available to patients on the NHS. NHS England is currently in the early stages of policy development for chemosaturation to treat metastatic uveal melanoma where surgery to remove or destroy affected cells and tissue in the liver is not feasible.
National Institute for Health and Care Excellence (NICE) guidance recommends that chemosaturation can be used for patients with secondary liver metastases resulting from a primary ocular melanoma, provided special arrangements are in place. A special arrangements recommendation states that clinicians using the procedure should inform the clinical governance lead in their trust, tell the patient about the uncertainties regarding the safety and efficacy of the procedure, and collect further data by means of audit or research. NICE is in the process of updating its guidance, with final guidance expected on 15 October 2026. The first committee meeting, to discuss the evidence, is expected to take place on 16 April 2026. Further information is available at the following link:
https://www.nice.org.uk/guidance/indevelopment/gid-ipg10448
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with NHS England on the publication date for the draft commissioning policy for Chemosaturation therapy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department and the National Health Service in England are committed to ensuring that cancer patients have timely access to treatment and tailored medical support. In 2016, NHS England concluded that there was insufficient evidence to make chemosaturation treatment available to patients on the NHS. NHS England is currently in the early stages of policy development for chemosaturation to treat metastatic uveal melanoma where surgery to remove or destroy affected cells and tissue in the liver is not feasible.
National Institute for Health and Care Excellence (NICE) guidance recommends that chemosaturation can be used for patients with secondary liver metastases resulting from a primary ocular melanoma, provided special arrangements are in place. A special arrangements recommendation states that clinicians using the procedure should inform the clinical governance lead in their trust, tell the patient about the uncertainties regarding the safety and efficacy of the procedure, and collect further data by means of audit or research. NICE is in the process of updating its guidance, with final guidance expected on 15 October 2026. The first committee meeting, to discuss the evidence, is expected to take place on 16 April 2026. Further information is available at the following link:
https://www.nice.org.uk/guidance/indevelopment/gid-ipg10448
Asked by: Damien Egan (Labour - Bristol North East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of Yellow Card reporting for capturing cases of Topical Steroid Withdrawal.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department, with responsibility for ensuring medicines meet appropriate standards of safety, quality, and efficacy.
In 2021, the MHRA published a Public Assessment Report (PAR), reviewing the available evidence for topical steroid withdrawal (TSW) reactions, which can be found at the following link:
To inform this report, a comprehensive review of the available evidence was undertaken. This included an assessment of data from Yellow Card reports to identify suspected spontaneous cases of TSW reactions associated with topical corticosteroids on the Yellow Card database, as well as information from the published literature and other medicines regulators. The review considered whether regulatory action was required to minimise the risk of these events.
The PAR resulted in two Drug Safety Updates in 2021 and 2024 which aimed to raise awareness on the risk of TSW reactions and introduce new labelling. Both updates are available, respectively, at the following two links:
The MHRA uses the Medical Dictionary for Regulatory Activities (MedDRA) to code suspected adverse drug reactions reported by patients and healthcare professionals via the Yellow Card scheme. MedDRA is an international, clinically validated medical terminology used by regulatory authorities and the biopharmaceutical industry throughout the entire regulatory process, from pre-marketing to post-marketing safety monitoring. MedDRA is updated twice annually, and new terms can be proposed by any MedDRA users. Following the publication of the PAR, the term “Topical steroid withdrawal reaction” was added to MedDRA as a lower level term in version 24.1 and made available to users of the Yellow Card website in February 2022 as part of routine updates. This helps to ensure that more reports pertaining to TSW reactions are appropriately captured. The MHRA continues to closely monitor Yellow Card reports submitted for suspected TSW reactions.
The MHRA continues to engage with the British Association of Dermatologist who have also released a statement, which is available at the following link:
https://cdn.bad.org.uk/uploads/2024/02/22095550/Topical-Steroid-Withdrawal-Joint-Statement.pdf
Asked by: James McMurdock (Independent - South Basildon and East Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the Department is taking to ensure that AI systems used in A&E departments comply with NHS data governance, patient privacy and cybersecurity requirements.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is dedicated to ensuring patient privacy while leveraging artificial intelligence (AI) in healthcare. We have engaged patients and the public in discussions on how and why health data should be accessed for AI systems. The Department and NHS England have implemented robust data protection measures, including Data Protection Impact Assessments and adherence to UK General Data Protection Regulation, to safeguard patient data. All National Health Service trusts and providers must complete a Digital Technology Assessment Criteria (DTAC) assessment to fully assure that the technologies they use are safe, effective, and that data is protected. This includes technologies used in accident and emergency departments. The DTAC evaluates products to ensure NHS standards for safety, usability, and accessibility are met, with clear evidence requirements and scoring criteria included for each area.
The accident and emergency demand forecasting tool, within the NHS England Federated Data Platform, is trained on pseudonymised data, and with only aggregate non-patient level outputs reaching the dashboard users. Regular risk reviews occur to ensure it is as low risk as possible in terms of cyber security and patient privacy and that it follows NHS data governance.
The Department and the NHS England Information Governance Team provide guidance for patients, health care professionals, and information governance professionals on the use of AI in the NHS and NHS settings such as accident and emergency departments.
The Department works closely with the NHS and its suppliers to share threat intelligence on evolving AI cyber threats.
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what vetting procedures are in place to ensure care agencies providing non UK workers in the care industry ensure the safety of patients before allowing workers to commence a caring role.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Care agencies who carry out a regulated activity must be registered by the Care Quality Commission (CQC) and are expected to comply with relevant regulations. Where a care agency does not carry out a regulated activity but supplies workers to a regulated care provider, the legal duty to comply with CQC regulations sits with the registered provider using the agency and the registered manager.
Regulation 19 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 sets out that it is the responsibility of the regulated provider to ensure robust and safe recruitment practices are in place, and to make sure that all staff, including agency staff, are suitably experienced, competent, and able to carry out their role. Further information on Regulation 19 is avaiable at the following link:
Registered providers are also expected to comply with Regulation 18: Staffing, which sets out a provider’s responsibility to deploy enough suitably qualified, competent, and experienced staff. Further information on Regulation 18 is avaiable at the following link:
The CQC can assess compliance with these regulations through assessment and monitoring activity. Where a breach of regulation or non-compliance is identified, the CQC can take regulatory action.
An Enhanced Disclosure and Barring Service (DBS) check must be undertaken prior to the recruitment of all care workers. In line with the CQC guidance for DBS checks, staff working with vulnerable adults can only start work before a DBS certificate is received if they have had a DBS Adult First Check, are appropriately supervised, and do not escort people away from the premises unless accompanied by someone with a DBS check.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the backlog maintenance costs for GP surgeries and other primary care premises in England.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There is no separate assessment of general practice (GP) premises as part of the Care Quality Commission’s (CQC) assessments of practices. The CQC’s Premises Regulations, primarily Regulation 15, mandate that care locations must be clean, suitable, secure, and properly maintained, ensuring safety for users. As of 15 January 2026, in England there are 5,520 GP surgeries rated as Good, 256 rated as Requires Improvement, and 20 rated as Inadequate. five locations have yet to be rated.
The Government recognises the importance of strategic, value for money investments in capital projects, such as new facilities, significant upgrades, or other targeted capital investments.
In May, we announced schemes which will benefit from the £102 million Primary Care Utilisation and Modernisation Fund to deliver upgrades to more than a thousand GP surgeries across England this financial year. These schemes will create additional clinical space within existing building footprints to enable practices to see more patients, boost productivity, and improve patient care.
NHS England is responsible for funding allocations to integrated care boards (ICBs). This process is independent of the Government, and NHS England takes advice on the underlying formula from the independent Advisory Committee on Resource Allocation (ACRA). The most recent allocations take into account an ACRA-recommended change specifically focused on rurality.
ICBs are responsible for commissioning, which includes planning, securing, and monitoring, GP services within their health systems through delegated responsibility from NHS England. The NHS has a statutory duty to ensure there are sufficient medical services, including general practices, in each local area. It should take account of population growth and demographic changes.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the additional costs of maintaining and developing primary care estates in island, rural, and coastal communities.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There is no separate assessment of general practice (GP) premises as part of the Care Quality Commission’s (CQC) assessments of practices. The CQC’s Premises Regulations, primarily Regulation 15, mandate that care locations must be clean, suitable, secure, and properly maintained, ensuring safety for users. As of 15 January 2026, in England there are 5,520 GP surgeries rated as Good, 256 rated as Requires Improvement, and 20 rated as Inadequate. five locations have yet to be rated.
The Government recognises the importance of strategic, value for money investments in capital projects, such as new facilities, significant upgrades, or other targeted capital investments.
In May, we announced schemes which will benefit from the £102 million Primary Care Utilisation and Modernisation Fund to deliver upgrades to more than a thousand GP surgeries across England this financial year. These schemes will create additional clinical space within existing building footprints to enable practices to see more patients, boost productivity, and improve patient care.
NHS England is responsible for funding allocations to integrated care boards (ICBs). This process is independent of the Government, and NHS England takes advice on the underlying formula from the independent Advisory Committee on Resource Allocation (ACRA). The most recent allocations take into account an ACRA-recommended change specifically focused on rurality.
ICBs are responsible for commissioning, which includes planning, securing, and monitoring, GP services within their health systems through delegated responsibility from NHS England. The NHS has a statutory duty to ensure there are sufficient medical services, including general practices, in each local area. It should take account of population growth and demographic changes.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the condition of the primary care estate in England; and what proportion of GP premises are currently rated as (a) good, (b) requiring improvement, and (c) unfit for purpose.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There is no separate assessment of general practice (GP) premises as part of the Care Quality Commission’s (CQC) assessments of practices. The CQC’s Premises Regulations, primarily Regulation 15, mandate that care locations must be clean, suitable, secure, and properly maintained, ensuring safety for users. As of 15 January 2026, in England there are 5,520 GP surgeries rated as Good, 256 rated as Requires Improvement, and 20 rated as Inadequate. five locations have yet to be rated.
The Government recognises the importance of strategic, value for money investments in capital projects, such as new facilities, significant upgrades, or other targeted capital investments.
In May, we announced schemes which will benefit from the £102 million Primary Care Utilisation and Modernisation Fund to deliver upgrades to more than a thousand GP surgeries across England this financial year. These schemes will create additional clinical space within existing building footprints to enable practices to see more patients, boost productivity, and improve patient care.
NHS England is responsible for funding allocations to integrated care boards (ICBs). This process is independent of the Government, and NHS England takes advice on the underlying formula from the independent Advisory Committee on Resource Allocation (ACRA). The most recent allocations take into account an ACRA-recommended change specifically focused on rurality.
ICBs are responsible for commissioning, which includes planning, securing, and monitoring, GP services within their health systems through delegated responsibility from NHS England. The NHS has a statutory duty to ensure there are sufficient medical services, including general practices, in each local area. It should take account of population growth and demographic changes.
Asked by: Joe Robertson (Conservative - Isle of Wight East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what funding has been allocated for the improvement and expansion of the primary care estate in each of the last five financial years.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
There is no separate assessment of general practice (GP) premises as part of the Care Quality Commission’s (CQC) assessments of practices. The CQC’s Premises Regulations, primarily Regulation 15, mandate that care locations must be clean, suitable, secure, and properly maintained, ensuring safety for users. As of 15 January 2026, in England there are 5,520 GP surgeries rated as Good, 256 rated as Requires Improvement, and 20 rated as Inadequate. five locations have yet to be rated.
The Government recognises the importance of strategic, value for money investments in capital projects, such as new facilities, significant upgrades, or other targeted capital investments.
In May, we announced schemes which will benefit from the £102 million Primary Care Utilisation and Modernisation Fund to deliver upgrades to more than a thousand GP surgeries across England this financial year. These schemes will create additional clinical space within existing building footprints to enable practices to see more patients, boost productivity, and improve patient care.
NHS England is responsible for funding allocations to integrated care boards (ICBs). This process is independent of the Government, and NHS England takes advice on the underlying formula from the independent Advisory Committee on Resource Allocation (ACRA). The most recent allocations take into account an ACRA-recommended change specifically focused on rurality.
ICBs are responsible for commissioning, which includes planning, securing, and monitoring, GP services within their health systems through delegated responsibility from NHS England. The NHS has a statutory duty to ensure there are sufficient medical services, including general practices, in each local area. It should take account of population growth and demographic changes.